Author Guidelines

The Drug and Advanced Sciences Journal (DASJ) is a peer-reviewed multi-disciplinary journal providing a medium to disclose new experimental and theoretical achievements in all areas of pharmaceutical and drug related sciences. The aim of the Drug and Advanced Sciences Journal is to publish original research papers and invited reviews provided that there is an adaptable advance in the presented knowledge. Scientific topics of interest to the journal include, but are not limited to: Pharmacology, Pharmaceutics, Pharmacognosy, Toxicology, Medicinal/Pharmaceutical Chemistry, Rational Drug Design, Computational drug design and Pharmacoinformatics, Clinical Pharmacy, Pharmacoeconomics, Pharmaceutical Biotechnology, Pharmaceutical Nanotechnology, Biopharmaceutics, Physical pharmacy, Pharmacogenetics and Pharmacogenomics.

It should be notified that papers in the field of pharmaceutical educational and subjects of entirely local interest will not be considered for publication.

Manuscript consideration

Types of papers that can be submitted for consideration by the Editorial Board include Original Research Papers and Reviews. The manuscript should provide full and appropriate credit to all who participated in the work. Each manuscript must be accompanied by a cover letter from the corresponding author (on behalf of other authors) declaring that:

1) The work has not been previously published, submitted to other journals or under evaluation in any language elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis).

2) All coauthors are aware of their participation in conducting the research leading to the manuscript and agree to its submission to be considered for publication by DASJ, and that all have agreed on the final version.

Any addition, removal or rearrangement of author names in the authorship list must be made only before the manuscript is accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Just in particular cases will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in an erratum.

Ethics in animal and clinical investigations

Investigations using human subjects/experimental animals must contain a statement confirming adherence of research to the protocols approved by the appropriate institutional care committee (provide the name of the committee) and be approved by the institutional ethics committee; and this should be stated in the “Methods” section with specifying any license(s) acquired to conduct the work.

In case of any doubt about the adherence of the research to the appropriate institutional care committee, it should be demonstrated that the doubtful aspects have been clearly approved by the relevant institutional ethics committee, and the rational for the approach should be explained. In clinical studies involving human subjects, the patients' right to privacy should be considered and any form of identifying information should not be published unless this is necessary for scientific purposes and the patient give written informed consent. 

Disclosure of potential conflict of interests

Any relationship or interests (financial & non-financial) with other people or organizations that could impact or bias the work must be disclosed by authors to provide more apparent assessment processing of the manuscript. If no conflict exists, the authors should state "The authors declare that they have no conflict of interest".

Double-blind review

Submissions meeting the journal’s requirements (regarding the field, scientific relevance and quality) will be subjected to double-blind review by expert national and international referees that are not necessarily members of Editorial Board. A double-blind review in which the identity of author(s) and reviewer(s) are concealed from each other supports a fair review process. The corresponding author may also suggest potential reviewers with their affiliation and e-mail addresses to the journal at the time of submission. Potential reviewers must be experts in the field of submitted study. However, the editorial board reserves the right to accept or reject the suggested reviewers.

Manuscript style

Research papers as well as review articles that address aims and scope of the journal will be considered for publication. The Articles should include title page, Abstract, Keywords, Introduction, Materials and methods, Results and discussion, Conclusion, acknowledgement, Conflict of interest, References, Tables (with captions) and Figures (with legends) enumerated from the title page. Manuscripts should be 1.5 line spaced with the whole text written in Times New Roman font (size 10). Page layout should be set at 1 inch per side. Figure legends and table captions have to be typed in Arial font (size 9). In the case of units, internationally accepted rules and conventions should be followed and the international system of units (SI) must be used. If other units are to be applied, relevant SI equivalent should be introduced in parentheses. The style of heading and subheadings might be illustrated by following example:

2. Materials and methods (Bold, Font size 12)

2.1. Biological assessments (Font size 12)

2.1.1. In vitro assessment (Italic, Font size 11)

There are no restrictions on the length of an article but authors are requested to write their manuscripts in a clear and concise manner with correct grammar, spelling and punctuation.

Title Page: This should include title, authors' details (first name/surname, their institutional affiliation) and name, address, phone/fax number of author to whom correspondence should be addressed.

Abstract: This should include a single paragraph comprising not be more than 250 words and without any citation(s). The abstract must summarize the entire paper.

Keywords: For indexing purposes, each submitted article should include 4 to 6 keywords.

Acknowledgment: In this section any financial support, scientific or technical assistance should be acknowledged with writing the full name of funding/assisting source. All individuals acknowledged should be aware of the fact and agree to inclusion.

Citations: Cite references in the text by number in brackets, e.g.: [2]. The list of references should merely include works that are cited in the text and that have been published. Personal communications and unpublished data or reports should only be mentioned in the text.

References: The authors are responsible for the accuracy of the bibliographic information. References must be numbered consecutively in order of their citation in the text. Reference style should be in Vancouver format. For those authors that use EndNote software, Vancouver style is available in word medium subsequent to the installation of EndNote.

Tables: The Tables should provide easier understanding and not duplicate information already included in the text or figures. Tables should be included in the main text and numbered with Arabic numerals (Table 1, 2, 3) according to their consecutive citation in the text. Each table should be supplied with a concise caption (title) above the table. Tables must be self-explanatory and hence enable readers to interpret them without referring to the text. Where required, footnotes to Tables that are designated by alphabets can be used. Table captions begin with the term Table in bold type, followed by the Table number, also in bold type with no punctuations after the number or at the end of the caption (e.g., Table 1 Molecular properties of ...).

Tables should not be divided into separate sections (e.g., Table 1a and Table 1b) but where necessary, separate tables (Table 1, Table 2) or combined data under the same columns or rows can be used.

Figures/schemes: All Figures should be in JPG or TIFF format and graphs should be professionally prepared in deep-black and submitted as glossy, black-and-white clean photostats. Professionally designed computer generated graphs with a minimum of 300 dpi laser printer output is also acceptable. For schematic representation of chemical structures, authors are strongly recommended to use font size 14 and font style of Arial in bold format with ChemDraw and ISIS Draw. All figures should be embedded in the main text and numbered using Arabic numerals (Fig 1, 2, 3) as cited in the sequential order in the text. Figures/schemes should be supplied with a concise legend below it. Color photographs are welcome at no extra charge. Various figure parts should be designated by lowercase letters (a, b, c, etc.). Figures must be self-explanatory and hence enable readers to interpret them without referring to the text. Figure legends begin with the term Fig in bold type, followed by the figure number, also in bold type with no punctuations after the number or at the end of the legend (e.g., Fig 1 Effect of ...). 

Submission of manuscript

Submission of a manuscript implies that it has not been published previously (except in the form of an abstract, a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. 

Original research works in two forms of research paper or reviews could be submitted electronically through The manuscripts should be written in clear and concise English. Authors are responsible for all statements made in their work. The right is reserved to integrate any change that is thought necessary by the Editorial Board to make contributions synchronize the editorial standards of the Journal.

Copyright Transfer

A statement transferring copyright from the authors to DASJ will be required before the manuscript can be accepted for publication. All the articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g. as offprints), as well as all translation right. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic databases, video disks, etc. without first obtaining written permission from the publisher. The use of general descriptive names, trade names, trademarks, in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Anti-Plagiarism Policy

Manuscripts must be devoid of any forms of plagiarism. They should also have appropriate citations to the related literature in the field.

Contact information

For further information, please contact the Editorial Office through:

Tel: +98-45-33522437

Fax: +98-21-33522197